In vitro immune evaluation of adenoviral vector-based platform for infectious diseases.
Baran J, Kuryk Ł, Szczepińska T, Łaźniewski M, Garofalo M, Mazurkiewicz-Pisarek A, Mikiewicz D, Mazurkiewicz A, Trzaskowski M, Wieczorek M, Pancer K, Hallmann E, Brydak L, Plewczynski D, Ciach T, Mierzejewska J, Staniszewska M.
Baran J, et al.
BioTechnologia (Pozn). 2023 Dec 21;104(4):403-419. doi: 10.5114/bta.2023.132775. eCollection 2023.
BioTechnologia (Pozn). 2023.
PMID: 38213479
Free PMC article.
New prophylactic vaccine platforms are imperative to combat respiratory infections. The efficacy of T and B memory cell-mediated protection, generated through the adenoviral vector, was tested to assess the effectiveness of the new adenoviral-based platforms for infectious …
New prophylactic vaccine platforms are imperative to combat respiratory infections. The efficacy of T and B memory cell-mediated prot …